期刊文献+

微血管自律运动在高血压发生发展中的变化和意义 被引量:2

Microvascular Vosomotion Changes in Occurrence and Development of Hypertension
原文传递
导出
摘要 微循环的异常,包括微血管的稀疏和(或)微血管结构的改变,可能参与了高血压的发生发展,是造成终末器官缺血和功能障碍直至衰竭的主要原因之一。根据文献报道,微血管自律运动调控血流动力学的同时还参与信息传递并适时作出反应,改善组织灌注不足、缺血、缺氧,缓解外周压力。已有研究发现,高血压发生发展过程中,微血管自律运动频率和振幅呈现复杂的变化,可能与内皮细胞功能不足、细胞间缝隙连接减少、平滑肌细胞钙离子内流增多及钙池功能异常引起膜电位改变等有关,本文将从微循环的角度阐述高血压状态下微血管自律运动的变化并对其机制做一简要概述。 Microcirculatory abnormalities including microvascular rarefaction and (or) structural changes might be involved in occurrence and development of hypertension and is a major cause of end-organ damage. Many results have been emerged that microvascular vasomotion not only played a significant role in hemodynamic of blood circulating system, but also participated in information signaling, improving organ perfusion inadequacy, ischemia-hypoxia and peripheral vascular resistance. The relationship between hypertension and micro vascular vasomotion is well established showing complicated changes both in amplitude and frequency at different development stage of hypertension. Furthermore, mounting evidences about regulatory mechanisms for complicated changes in hypertension have been sprouted up that it might be related with end0thelium dysfunction, limited number of gap junctions and membrane potential calcium influx. Therefore, one important perspective might be provided by microvascular vasomotion to investigate the pathophysiological changes in hypertension, and the underlying mechanisms would be briefly reviewed.
出处 《现代生物医学进展》 CAS 2014年第8期1580-1582,1586,共4页 Progress in Modern Biomedicine
关键词 微血管自律运动 高血压 内皮 膜电位 Vasomotion Hypertension Endothelium Membrane potential
  • 相关文献

参考文献28

  • 1修瑞娟,Intaglietta,M.微血管自律运动的研究[J].中华医学杂志,1985,65(3):129.
  • 2Jones, T.W. Discovery that the veins of the bat's wing are endowed with rhythmical contractility and that onward flow of blood is accelerated by each contraction [J]. Philos Trans R Soc Lond B Biol Sci, 1852,142, 131-136.
  • 3Xiu,R.J., Intaglietta M. Long-term analysis of microvascular vosomotion and the effect ofvasoactive substances[J].J Int Microvasc Res,1983, 25:262.
  • 4Xiu, R.J., Intaglietta,M. Extreme wave-like tissue perfusion due to vosomotion enhancement by specialized Chinese vasoacive drugs[J]. Int J Microeirc Clin Exp,1984,3:511.
  • 5Clark, M. G. Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle [J]. Am J Physiol Endocrinol Metab, 2008,295(4):E732-50.
  • 6Paradhan RK. Informational dynamics of vasomotion in microvascular networs: a review[J]. Acta Physiol,2011,201(2): 193-218.
  • 7Gratton, R.J., Gandley, R.E., McCarthy, J.F., et al. Contribution of vasomotion to vascular resistance: a comparison of arteries from virgin and pregnant rats[J]. J Appl Physio, 1998,185:2255-2260.
  • 8Aalkjaer, C., Danielsen, H., Johannesen, P. Abnormal vascular function and morphology in pre-eclampsia: a study of isolated resistance vessels[J]. Clin Sci (Lond), 1985, 69:477-482.
  • 9Lefer, D.J., Lynch, C.D., Lapinski, K.C. Enhanced vasomotion of cerebral arterioles in spon-taneously hypertensive rats [J]. Mierovasc Res,1990,39:129-139.
  • 10Bertuglia, S., Colantuoni, A., Coppini, G, et al. Hypoxiaor hyperoxia- induced changes in arteriolar vasomotion in skeletal muscle microcireulation [J]. Am J Physiol, 1991,260:H362-H372.

二级参考文献18

  • 1朱小玲,李庆祥,张宇清,慈维苹,艾辉,陈祚,吴海英,颜红兵,刘国仗.血管紧张素Ⅱ1型受体基因A1166C多态性与高血压肾脏损害相关性研究[J].心肺血管病杂志,2006,25(3):135-137. 被引量:4
  • 2Ran YIN,Yu-gang DONG,Hong-liang LI.PPARγ phosphorylation mediated by JNK MAPK:a potential role in mac-rophage-derived foam cell formation[J].Acta Pharmacologica Sinica,2006,27(9):1146-1152. 被引量:6
  • 3Viazzi F, Leoncini G, Ratto E, et al, Vascular permeability, blood pressure, and organ damage in primary hypertension. Hypertens Res, 2008,31 : 873-879.
  • 4Myers MG. Recent advances in automated blood pressure measurement. Curr Hypertens Rep, 2008 , 10:355- 358.
  • 5Eguchi K, Pickering TG, Hoshide S, et al. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/ without type 2 diabetes. Am J Hypertens, 2005,21 : 443-450.
  • 6Gaborieau V, Delarche N, Gosse P. Ambulatory blood pressure monitoring versus self-measure ment of blood pressure at home: correlation with target organ damage. J Hypertens, 2008,26: 1919-1927.
  • 7Hansen TW, Li Y, Staessen JA. Blood pressure variability remains an elusive predictor of cardio-vascular outcome. Am J Hypertens, 2009,22:3-4.
  • 8Torun D, Sezer S, Arat Z, et al. The frequency of combined target organ damage and the beneficial effect of ambulatory blood pressure monitoring in never treated mild-to-moderate hypertensive patients. Int Heart J, 2005,46 : 1073-1082.
  • 9Pickering T. Schwartz J, Verdecchia P, et al. Prediction of strokes versus cardiac events by ambulatory monitoring of blood pressure: results from an international database. Blood Press Monit, 2007,12:397-399.
  • 10Rodendanz AR. Hypertension and chronic renal insufficiency. Acta Med AustRiaca, 2001,28: 66-69.

共引文献13

同被引文献44

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部